BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 6840666)

  • 1. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay for the detection of HBeAg and anti-HBe.
    Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients].
    Zivanović-Marinković V; Kaljalović R; Marinković V; Dumović B; Lazarov A; Nanusević N; Krstić L; Parabucki S
    Zb Vojnomed Akad; 1981; 23():24-6. PubMed ID: 6963836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers.
    Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
    Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.